View Clinical Trial (Medical Research Study)


Screening Protocol for Subjects Being Evaluated for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols

Signup
Browse Studies

City:   Bethesda
State:   Maryland
Zip Code:   20892
Conditions:   Inflammatory Disease - Autoimmune Disease - Immunologic Disease - Healthy Volunteers
Purpose:   Background: - For every CHI research study, patients must fulfill a list of criteria, based primarily on their medical condition. To determine whether a patient meets these eligibility criteria to participate in a research protocol, researchers must perform a series of diagnostic tests and procedures. - These evaluations are designed to evaluate a participant s general medical condition (i.e., blood tests, function of certain organs such as the lungs, heart, liver, or kidneys), and to confirm a diagnosis or ensure that a healthy volunteer is in good condition. They maximize the safety for the patients and healthy volunteers at CHI. Objective: - To determine the eligibility of patients and healthy volunteers for active CHI research protocols. Eligibility: - The procedures included in this protocol will determine eligibility for active CHI research protocols. - Both healthy volunteers and patients will be evaluated. Design: - Required tests and procedures for various research studies may include the following: history and physical examination, blood and urine tests, lung and heart function tests (echocardiogram, electrocardiogram, stress test), imaging studies (X-rays, magnetic resonance imaging (MRI), computerized tomography (CT), and tissue collection. - Participants will be asked to undergo tests only for the study or studies for which they are being considered. The research team will provide further information on any additional tests that may be required. - After all eligibility assessments are complete, participants may be offered participation in one or more CHI research protocols or referred back to a home physician.
Study Summary:   This protocol is designed for screening of subjects prior to a decision as to their eligibility for participation on a Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) tissue procurement or investigative therapy protocol. The purpose of the protocol is to allow investigation into any underlying immunologic and/or inflammatory processes and to assess the status of organ systems, important both to determine suitability for participation on specific protocols and/or ability to safely tolerate tissue procurement or investigative treatments and procedures. It also allows the investigation as to whether subjects are eligible for participation as a volunteer based on eligibility criteria that include generally good health status by history and physical examination and laboratory assessment. After completion of the screening process, the subject will either be offered an opportunity to participate in a specific research protocol, or if no appropriate protocol is identified, will have recommendations for other treatment options conveyed to the primary or referring physician. Primary objective is to determine subject eligibility for participation on Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) tissue procurement or investigative therapy protocols. Primary endpoint is the results of clinical, imaging and laboratory assessments.
Criteria:   - INCLUSION CRITERIA: 1. Diagnosed with a disorder for which the CHI has an active research protocol, and based on information received from an outside physician, the patient appears to meet at least preliminary eligibility criteria for that protocol. OR Self proclaimed healthy volunteer for whom the CHI has a study actively recruiting healthy volunteers and he/she appears to meet preliminary eligibility as a healthy volunteer. 2. Age greater than or equal to 2 (healthy volunteers greater than or equal to 8) 3. Weight greater than 12 kg 4. The subject or the subject s guardian is capable of informed consent, and willing to sign the consent form after initial counseling by clinical staff. Separate consent forms for all interventional or surgical procedures will be obtained after explanation of the specific procedure. EXCLUSION CRITERIA: All subjects not fulfilling the inclusion criteria will be considered ineligible.
NCT ID:   NCT00968084
Primary Contact:   Principal Investigator
Neal S Young, M.D.
National Heart, Lung, and Blood Institute (NHLBI)

Shira Y Perl, M.D.
Phone: (301) 594-0512
Email: perls@mail.nih.gov
Backup Contact:   Email: youngns@mail.nih.gov
Neal S Young, M.D.
Phone: (301) 496-5093
Location Contact:   Bethesda, Maryland 20892
United States

For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL)
Phone: 800-411-1222
Email: prpl@mail.cc.nih.gov

Site Status: Recruiting

Data Source:   ClinicalTrials.gov
Date Processed:   October 23, 2014
Modifications to this listing:   Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


  • NEARBY STUDIES

    (updated 57 minutes ago)
Within 25 Miles

Endometriosis - Washington DC

Adolescent Major Depression (Ages 12-17) - Washington DC

Heart Failure After Heart Attack - Washington DC

Multiple Sclerosis - Washington DC

Healthy Volunteers - NY, NJ, PA, DE, DC, MD or VA

Diabetic Gastroparesis - Burke VA

High Cholesterol - Burke VA

Polycystic Kidney Disease (PKD) - Autosomal Dominant (ADPKD) - Arlington VA

Healthy Volunteers - Rockville MD

Polycystic Kidney Disease (PKD) - Autosomal Dominant (ADPKD) - Rockville MD

Adolescent Major Depression (Ages 12-17) - Rockville MD

Asthma - Fairfax VA

Polycystic Kidney Disease (PKD) - Autosomal Dominant (ADPKD) - Bethesda MD

Diabetic Kidney Disease - Rockville MD

Diabetic Kidney Disease - Fairfax VA

Osteoporosis (resulting from steroid medication use) - Bethesda MD

Grave's Disease and hyperthyroidism - NY, NJ, PA, DE, DC, MD or VA

Birth Control Patch - Rockville MD

Psoriasis - NY, NJ, PA, DE, DC, MD or VA

Asthma - Columbia MD

Nerve Pain - Arlington VA

Within 50 Miles

Type 2 Diabetes - Baltimore MD

Adolescent Major Depression (Ages 12-17) - Baltimore MD

Alzheimer's Disease - Baltimore MD

Temporomandibular Disorder (TMJD) - Baltimore MD

Healthy Volunteers (Age 18-45) - Baltimore MD

Healthy Volunteers (Age 18-60) - Baltimore MD

Healthy Volunteers (Age 18-49) - Baltimore MD

Healthy Volunteers (Age 25-40) - Baltimore MD

Diabetic Gastroparesis - Manassas VA

Healthy Volunteers (Age 18-60) - Baltimore MD

Healthy Volunteers (Age 50-80) - Baltimore MD

Asthma - Baltimore MD

Healthy Female Volunteers (Age 18-35) - Baltimore MD

Healthy Female Volunteers (Age 50-65) - Baltimore MD

Eczema - Baltimore MD

Allergies - Baltimore MD

Healthy Female Volunteers (Age 18-39) - Baltimore MD

Type 2 Diabetes - Nottingham MD

High Cholesterol - Manassas VA

Stress Urinary Incontinence (SUI) - Glen Burnie MD

COPD (Emphysema and Chronic Bronchitis) - White Marsh MD

Alcoholics Anonymous/Narcotics Anonymous Survey - Fredericksburg VA

Healthy Male Volunteers (Age 18-50) - Baltimore MD

Type 2 Diabetes - Baltimore MD

Asthma - Nottingham MD

Healthy Volunteers (Age 18-65) - Baltimore MD

Flu - Towson MD

Cushing's Syndrome - Baltimore MD

Within 100 Miles

Endometriosis - Hershey PA

Endometriosis - Newark DE

Pediatric Depression - Richmond VA

Asthma - Henrico VA

Adolescent Major Depression (Ages 12-17) - Richmond VA

Heart Failure After Heart Attack - Lemoyne PA

Dust Mite Allergy - Henrico VA

Chronic Idiopathic Constipation - Richmond VA

Eczema - Richmond VA

Pediatric Asthma - Richmond VA

Severe Asthma - Richmond VA

Children with Asthma - Richmond VA

Endometriosis - Richmond VA

Postmenopausal Osteoporosis - Richmond VA

Type 2 Diabetes - Winchester VA

Weight Management and Cardiovascular Disease - Henrico VA

COPD (Emphysema and Chronic Bronchitis) - Richmond VA

Asthma - Richmond VA

Asthma in Children (Ages 5-11) - Richmond VA